Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Immunol. 1996 Oct;8(5):664-9.

    Recombinant Listeria monocytogenes cancer vaccines.

    Source

    Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA. yvonne@mail.med.upenn.edu

    Abstract

    Listeria monocytogenes has recently been exploited as a vector for targeting antigens to the immune system. In the past year it has been shown to be particularly effective as a tumor antigen vector. Here we set its potency as a cancer vaccine in the context of the type of immunity induced by this facultative intracellular bacterium.

    PMID:
    8902392
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk